These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 38654241)
21. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma. Vural GU; Akkas BE; Demirel BB Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135 [TBL] [Abstract][Full Text] [Related]
22. Combined pretreatment with Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736 [TBL] [Abstract][Full Text] [Related]
23. The role of Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206 [TBL] [Abstract][Full Text] [Related]
24. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer. Martinez A; Chantalat E; Angeles MA; Ferron G; Ducassou A; Daix M; Attal J; Bétrian S; Lusque A; Gabiache E BMC Cancer; 2022 Jul; 22(1):810. PubMed ID: 35870900 [TBL] [Abstract][Full Text] [Related]
25. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
26. Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters. Lawal IO; Lengana T; Janse van Rensburg C; Reyneke F; Popoola GO; Ankrah AO; Sathekge MM PLoS One; 2019; 14(4):e0215412. PubMed ID: 30998728 [TBL] [Abstract][Full Text] [Related]
27. Development and validation of a Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351 [TBL] [Abstract][Full Text] [Related]
28. Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on Zhang Y; Hu Y; Zhao S; Xu S Abdom Radiol (NY); 2024 Jun; 49(6):2027-2039. PubMed ID: 38526594 [TBL] [Abstract][Full Text] [Related]
29. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
30. Prognostic values of ADC Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907 [TBL] [Abstract][Full Text] [Related]
31. Metabolic parameters of [ Markus M; Sartor H; Bjurberg M; Trägårdh E Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676 [TBL] [Abstract][Full Text] [Related]
32. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis. Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659 [TBL] [Abstract][Full Text] [Related]
33. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [ Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366 [TBL] [Abstract][Full Text] [Related]
34. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions. Morkel M; Ellmann A; Warwick J; Simonds H Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535 [TBL] [Abstract][Full Text] [Related]
35. Prediction of outcome using pretreatment Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685 [TBL] [Abstract][Full Text] [Related]
36. Added value of para-aortic surgical staging compared to De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203 [TBL] [Abstract][Full Text] [Related]
37. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation. Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy. Cho HW; Lee ES; Lee JK; Eo JS; Kim S; Hong JH Ann Nucl Med; 2023 Jan; 37(1):44-51. PubMed ID: 36369325 [TBL] [Abstract][Full Text] [Related]
39. Value of Intratumoral Metabolic Heterogeneity and Quantitative Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078 [No Abstract] [Full Text] [Related]
40. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Onal C; Reyhan M; Parlak C; Guler OC; Oymak E Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]